Optimizing PCI Outcomes: Challenges in 2011

Home

Overview - Home

This symposium will comprehensively cover the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease. Those attending will be exposed to the latest clinical trial data on current and second-generation drug-eluting stent device-based therapies.

Controversies, including resistance and selection, of antiplatelet therapy as adjunctive treatment with percutaneous intervention will be discussed along with the use of imaging tools and how to manage complex lesions. Utilizing both didactic and case-based presentations, attendees will be exposed to the latest clinical and evidence-based medicine options to optimize patient outcomes in the treatment of coronary artery disease.

Course Directors

Martin B. Leon, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

Gregg W. Stone, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

This event is not part of the official ACC Annual Scientific Session and/or the American College of Cardiology’s Innovation in Intervention: i2 Summit in partnership with the Cardiovascular Research Foundation (CRF) as planned by their Program Committees.

CRF Meetings Mobile App

Download the FREE CRF Meetings mobile app to search agendas, exhibitors, faculty, add sessions to your calendar, get up-to-date cardiovascular news and much more.

Missed The 2010 Symposium?

Subscribe to TCTMD Gold for access to 2010 Optimizing PCI Outcomes: Evolving Paradigms presentations, other CRF conference presentations and premium content throughout the year in a unique, multimedia format.